Endogenous Noradrenaline Activates α2‐Adrenoceptors on Serotonergic Nerve Endings in Human and Rat Neocortex

Authors:
  • VVV. Van Velthoven
    V. Van Velthoven

Abstract
Slices from human neocortex preincubated with [3H]serotonin ([3H]5‐HT) were superfused and stimulated electrically to investigate whether the α2‐adrenoceptors on serotonergic terminals can be stimulated by endogenous noradrenaline (NA) released from neighboring noradrenergic fibers. The stimulation‐evoked3H overflow, representing action potential‐induced, exocytotic release of 5‐HT, was depressed by the NA uptake blocker (+)‐oxaprotiline. Rauwolscine (a mixed α2‐adrenoceptor antagonist/5‐HT autoreceptor agonist) or phentolamine [a combined α‐ adrenoceptor/5‐HT autoreceptor antagonist; the latter drug in the presence of (+)‐oxaprotiline] enhanced the release when the 5‐HT autoreceptors had previously been blocked by metitepine. Under hypothermia the release of 5‐HT was found to be decreased and that of NA to be increased; under these conditions idazoxan (an α2‐adrenoceptor antagonist) enhanced the release of 5‐HT. In neocortex slices from rats (+)‐oxaprotiline similarly depressed the release of 5‐HT (measured with the same methods) as in human tissue. When rats were pretreated with 6‐hydroxydopamine, the inhibitory effect of exogenous NA on 5‐HT release was increased, and in slices from rats pretreated with desipramine, it was decreased. In conclusion, α2‐heteroreceptors can be activated by endogenous NA released from neighboring noradrenergic fibers. Because regulatory processes analogous to those in rats probably occur in humans as well, an up‐ or down‐regulation of α2‐ heteroreceptors in depressed patients with a (pathological) decrease or a (therapeutic) enhancement of the noradrenergic neurotransmission may also be assumed to occur.

This publication has 18 references indexed in Scilit: